| 1 |
Al-shbool G, Krishnan Nair H. SMARCA4-Deficient Undifferentiated Tumor: A Rare Malignancy With Distinct Clinicopathological Characteristics. Cureus 2022. [DOI: 10.7759/cureus.30708] [Reference Citation Analysis]
|
| 2 |
Dihowm H, Amin M, Ballentine S. SMARCB1(INI1)-deficient undifferentiated carcinoma with rhabdoid features of anorectal origin. Current Problems in Cancer: Case Reports 2021;4:100095. [DOI: 10.1016/j.cpccr.2021.100095] [Reference Citation Analysis]
|
| 3 |
Schwartz CJ, Pareja F, da Silva EM, Selenica P, Ross DS, Weigelt B, Brogi E, Reis-Filho JS, Wen HY. Histologic and genomic features of breast cancers with alterations affecting the SWI/SNF (SMARC) genes. Mod Pathol 2021;34:1850-9. [PMID: 34079072 DOI: 10.1038/s41379-021-00837-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 4 |
Liu Z, Seshadri M, Gupta V, Papanicolau-Sengos A, Merzianu M. INI1-Deficient Thyroid Carcinoma is an Aggressive Disease with Epithelioid and Rhabdoid Phenotype. A Case Report, Survey of INI1 Expression in Thyroid Lesions and Literature Review. Head Neck Pathol 2021;15:1246-52. [PMID: 34057693 DOI: 10.1007/s12105-021-01338-0] [Reference Citation Analysis]
|
| 5 |
Gandhi JS, Alnoor F, Sadiq Q, Solares J, Gradowski JF. SMARCA4 (BRG1) and SMARCB1 (INI1) expression in TTF-1 negative neuroendocrine carcinomas including merkel cell carcinoma. Pathol Res Pract 2021;219:153341. [PMID: 33581550 DOI: 10.1016/j.prp.2021.153341] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 6 |
Velázquez Vega JE, Ballester LY, Schniederjan MJ. Tumors of the Central Nervous System. Practical Oncologic Molecular Pathology 2021. [DOI: 10.1007/978-3-030-73227-1_6] [Reference Citation Analysis]
|
| 7 |
Bennett JA, Lastra RR, Barroeta JE, Parilla M, Galbo F, Wanjari P, Young RH, Krausz T, Oliva E. Uterine Tumor Resembling Ovarian Sex Cord Stromal Tumor (UTROSCT): A Series of 3 Cases With Extensive Rhabdoid Differentiation, Malignant Behavior, and ESR1-NCOA2 Fusions. Am J Surg Pathol 2020;44:1563-72. [PMID: 32675660 DOI: 10.1097/PAS.0000000000001543] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 8 |
Momeni-Boroujeni A, Chiang S. Uterine mesenchymal tumours: recent advances. Histopathology 2020;76:64-75. [PMID: 31846533 DOI: 10.1111/his.14008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
|
| 9 |
Msaouel P, Malouf GG, Su X, Yao H, Tripathi DN, Soeung M, Gao J, Rao P, Coarfa C, Creighton CJ, Bertocchio JP, Kunnimalaiyaan S, Multani AS, Blando J, He R, Shapiro DD, Perelli L, Srinivasan S, Carbone F, Pilié PG, Karki M, Seervai RNH, Vokshi BH, Lopez-Terrada D, Cheng EH, Tang X, Lu W, Wistuba II, Thompson TC, Davidson I, Giuliani V, Schlacher K, Carugo A, Heffernan TP, Sharma P, Karam JA, Wood CG, Walker CL, Genovese G, Tannir NM. Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma. Cancer Cell 2020;37:720-734.e13. [PMID: 32359397 DOI: 10.1016/j.ccell.2020.04.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 16.3] [Reference Citation Analysis]
|
| 10 |
Rao P, Perrino CM, Zynger DL, Jorda M, Tamboli P, Sanchez DF, Cubilla AL, Iczkowski K, Zhang M, Sircar K. Genitourinary Pathology (Including Adrenal Gland). Oncological Surgical Pathology 2020. [DOI: 10.1007/978-3-319-96681-6_16] [Reference Citation Analysis]
|
| 11 |
Rekhtman N, Montecalvo J, Chang JC, Alex D, Ptashkin RN, Ai N, Sauter JL, Kezlarian B, Jungbluth A, Desmeules P, Beras A, Bishop JA, Plodkowski AJ, Gounder MM, Schoenfeld AJ, Namakydoust A, Li BT, Rudin CM, Riely GJ, Jones DR, Ladanyi M, Travis WD. SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas. J Thorac Oncol 2020;15:231-47. [PMID: 31751681 DOI: 10.1016/j.jtho.2019.10.023] [Cited by in Crossref: 96] [Cited by in F6Publishing: 107] [Article Influence: 24.0] [Reference Citation Analysis]
|
| 12 |
Sali AP, Chaubey V, Kodare D, Sahay A, Epari S. The Rare Phenomenon of Loss of INI1 Expression at Recurrence/Progression of Primary Central Nervous System Tumors: Report of 3 Cases. Int J Surg Pathol 2020;28:341-7. [DOI: 10.1177/1066896919883942] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 13 |
Stanescu AL, Acharya PT, Lee EY, Phillips GS. Pediatric Renal Neoplasms:: MR Imaging-Based Practical Diagnostic Approach. Magn Reson Imaging Clin N Am 2019;27:279-90. [PMID: 30910098 DOI: 10.1016/j.mric.2019.01.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 14 |
Msaouel P, Carugo A, Genovese G. Targeting proteostasis and autophagy in SMARCB1-deficient malignancies: where next? Oncotarget 2019;10:3979-81. [PMID: 31258836 DOI: 10.18632/oncotarget.26970] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 15 |
Kilic AI, Mirza K, Mehrotra S, Pambuccian SE. A BAFfling liver aspirate: Metastatic high grade SMARCA4 deficient undifferentiated gastroesophageal junction carcinoma masquerading as a hematolymphoid malignancy. Diagn Cytopathol 2019;47:725-32. [PMID: 30897306 DOI: 10.1002/dc.24174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 16 |
Lindsay H, Huang A. Atypical Teratoid Rhabdoid Tumors. Oncology of CNS Tumors 2019. [DOI: 10.1007/978-3-030-04152-6_33] [Reference Citation Analysis]
|
| 17 |
Matsushita M, Kuwamoto S. Cytologic Features of SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Comparison with Other SWI/SNF Complex-Deficient Tumors. Acta Cytol 2018;62:456-62. [PMID: 30286456 DOI: 10.1159/000493335] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 18 |
Velázquez Vega JE, Brat DJ. Incorporating Advances in Molecular Pathology Into Brain Tumor Diagnostics. Adv Anat Pathol 2018;25:143-71. [PMID: 29521646 DOI: 10.1097/PAP.0000000000000186] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 19 |
Wick MR. Primary lesions that may imitate metastatic tumors histologically: A selective review. Seminars in Diagnostic Pathology 2018;35:123-42. [DOI: 10.1053/j.semdp.2017.11.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 20 |
Rhabdoid Tumor of Kidney. Diagnostic Pathology: Pediatric Neoplasms 2018. [DOI: 10.1016/b978-0-323-54806-9.50166-x] [Reference Citation Analysis]
|
| 21 |
Pawel BR. SMARCB1-deficient Tumors of Childhood: A Practical Guide. Pediatr Dev Pathol 2018;21:6-28. [PMID: 29280680 DOI: 10.1177/1093526617749671] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 12.2] [Reference Citation Analysis]
|
| 22 |
Johnson DR, Guerin JB, Giannini C, Morris JM, Eckel LJ, Kaufmann TJ. 2016 Updates to the WHO Brain Tumor Classification System: What the Radiologist Needs to Know. RadioGraphics 2017;37:2164-80. [DOI: 10.1148/rg.2017170037] [Cited by in Crossref: 77] [Cited by in F6Publishing: 79] [Article Influence: 12.8] [Reference Citation Analysis]
|
| 23 |
Gürtl-Lackner B, Gisselsson-Nord D, Vujanic G. [Solid pediatric tumors : A brief survey of the rarity cabinet]. Pathologe 2017;38:278-85. [PMID: 28643124 DOI: 10.1007/s00292-017-0312-y] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
